|Bid||330.45 x 1200|
|Ask||330.04 x 1100|
|Day's range||308.24 - 331.00|
|52-week range||54.10 - 331.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||59.46|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.
Advice on retiring a millionaire reminds me of the old Steve Martin joke about how to be a millionaire: "First, get a million dollars." A more practical option, and one that has been proven effective, is to put your money to work in the stock market. This is not an unattainable goal, especially because you can buy growth stocks that do much better than the market index.
The market has been on edge over the new delta variant. Here are five stocks to help blunt a worst-case scenario.